Iti-1284

4 trials 3 recruiting

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

3 Recruiting

1 Completed trials

1 Sponsors

9 Countries

Phase II

Phase II: 4

Oversight events:

3 temporary halts across 1 trial

View oversight register →

Indications tested

Dementia Alzheimer's type 2 Dementia of the Alzheimer's type with delusions 1

Sponsors using this IMP

Intra-Cellular Therapies Inc. 4

All trials

4 total

A study to assess the efficacy and safety of ITI-1284 as adjunctive treatment in patients with Generalized Anxiety Disorder Recruiting

2024-513302-56-00 Phase II 4 countries Intra-Cellular Therapies Inc.
A study to assess the efficacy and safety of ITI-1284 as monotherapy treatment in patients with Generalized Anxiety Disorder Recruiting

2024-516684-82-00 Phase II 5 countries Intra-Cellular Therapies Inc.
A study to assess the efficacy and safety of ITI-1284 in the treatment of Psychosis Associated with Alzheimer's Disease Recruiting

2024-513035-25-00 Phase II 8 countries Intra-Cellular Therapies Inc.
A study to assess the efficacy and safety of ITI-1284 in the treatment of Agitation Associated with Alzheimer's Dementia Ended

2024-514680-26-00 Phase II 6 countries Intra-Cellular Therapies Inc.

Showing 1–4 of 4 trials

← All drugs A–Z